Want to see SER full AI Analyst Report?
Serina Therapeutics (SER) Stock Forecast & Price Target
SER Analyst Ratings
SER Stock 12 Month Forecast
Average Price Target
$9.50▲(389.69% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Thomas Shrader | BTIG | $8 | buy | 312.37%Upside | Reiterated | 10/26/26 | ||
| Justin Walsh | JonesTrading | $11 | buy | 467.01%Upside | Reiterated | 08/18/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Thomas Shrader | 10/26/26 | $8 | buy | 312.37%Upside | Reiterated | BTIG | ||
| Justin Walsh | 08/18/26 | $11 | buy | 467.01%Upside | Reiterated | JonesTrading |
Best Analysts Covering Serina Therapeutics
Copying Justin Walsh's trades and holding each position for 3 Months would result in 28.57% of your transactions generating a profit, with an average return of -8.20% per trade.
Copying Justin Walsh's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of -43.11% per trade.
Copying Justin Walsh's trades and holding each position for 2 Years would result in 14.29% of your transactions generating a profit, with an average return of -45.53% per trade.
SER Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 2 | 3 | 4 | 4 |
In the current month, SER has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SER average Analyst price target in the past 3 months is 9.50.
SER Financial Forecast
SER Earnings Forecast
Next quarter’s earnings estimate for SER is -$0.34 with a range of -$0.37 to -$0.31. The previous quarter’s EPS was -$0.55. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
SER Sales Forecast
Next quarter’s sales forecast for SER is $0 with a range of $0 to $0. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.